About Contact Us Careers
Sign In

Ultrasound Contrast Agents Market - Top Companies and Manufacturers

  • Report ID: 3241
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Companies Dominating the Ultrasound Contrast Agents Landscape

    • Bristol-Myers Squibb
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GE Healthcare
    • Lantheus Holdings, Inc.
    • Bracco Diagnostic Inc.
    • Merck & Company, Inc.
    • AstraZeneca Plc.
    • Siemens Healthcare GmbH
    • Mindray Medical International Limited
    • Daiichi Sankyo Company
    • Nano Therapeutics Pvt Ltd
Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3241
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Ultrasound Contrast Agents Market size is set to expand at over 19.8% CAGR during the forecast period i.e., between 2024-2036.

Rising prevalence of chronic disorders and increasing implementation of ultrasound diagnosis will fuel the market growth.

Asia Pacific is predicted to dominate majority revenue share by 2036, owing to increasing necessity for advanced diagnosis methods to detect various disease indications such as neurological disorders, cancer, cardiovascular diseases, and others.

The major players in the market include Bristol-Myers Squibb, GE Healthcare, Lantheus Holdings, Inc., Bracco Diagnostic Inc., Siemens Healthcare GmbH, and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample